TP53’s tumour suppressive properties may best be illustrated by the fact that germline mutations of TP53 are associated with the cancer predisposition Li-Fraumeni syndrome that can give rise to a multitude of different malignancies, including osteosarcoma. The gene discussed is TP53; the disease is neoplasm.